scholarly journals Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration

2015 ◽  
Vol 71 (2) ◽  
pp. 464-470 ◽  
Author(s):  
C. Roger ◽  
L. Muller ◽  
S. C. Wallis ◽  
B. Louart ◽  
G. Saissi ◽  
...  
Keyword(s):  
Renal Replacement Therapy ◽  
Replacement Therapy ◽  
Population Pharmacokinetics ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Continuous Venovenous Haemofiltration

scholarly journals Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

2008 ◽  
Vol 47 (3) ◽  
pp. 173-180 ◽  
Author(s):  
Arantxazu Isla ◽  
Alicia Rodríguez-Gascón ◽  
Iñaki F Trocóniz ◽  
Lorea Bueno ◽  
María Ángeles Solinís ◽  
...  
Keyword(s):  
Renal Replacement Therapy ◽  
Continuous Renal Replacement Therapy ◽  
Replacement Therapy ◽  
Population Pharmacokinetics ◽  
Critically Ill ◽  
Critically Ill Patients

scholarly journals Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy

2021 ◽  
Vol 9 (3) ◽  
Author(s):  
Jongsung Hahn ◽  
Kyoung Lok Min ◽  
Soyoung Kang ◽  
Seungwon Yang ◽  
Min Soo Park ◽  
...  
Keyword(s):  
Plasma Concentration ◽  
Renal Replacement Therapy ◽  
Critical Illness ◽  
Extracorporeal Membrane Oxygenation ◽  
Replacement Therapy ◽  
Population Pharmacokinetics ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Concentration Data ◽  
Dosing Optimization

To the best of our knowledge, this is the first large prospective pharmacokinetic/pharmacodynamic (PK/PD) study of piperacillin-tazobactam in ECMO patients. We used piperacillin-tazobactam plasma concentration data from four different cases (concomitant use of ECMO and CVVHDF, receiving ECMO only, weaned from ECMO and receiving CVVHDF, and weaned from ECMO and not receiving CVVHDF) to provide preliminary insights into the incremental effects of critical illness, ECMO, and CVVHDF on PK.

Sign in / Sign up

Export Citation Format

Share Document